{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T04:15:24Z","timestamp":1728360924973},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>The aim of this study was to evaluate gene therapy for AIDS based on the transduction of circulating lymphocytes with a retroviral vector giving low levels of constitutive macaque interferon \u03b2 production in macaques chronically infected with a pathogenic isolate of SIVmac251.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Two groups of three animals infected for more than one year with a pathogenic primary isolate of SIVmac251 were included in this study. The macaques received three infusions of their own lymphocytes transduced ex vivo with the construct encoding macaque IFN-\u03b2 (MaIFN-\u03b2 or with a vector carrying a version of the MaIFN-\u03b2 gene with a deletion preventing translation of the mRNA. Cellular or plasma viremia increased transiently following injection in most cases, regardless of the retroviral construct used. Transduced cells were detected only transiently after each infusion, among the peripheral blood mononuclear cells of all the animals, with copy numbers of 10 to 1000 per 10<jats:sup>6<\/jats:sup> peripheral mononuclear cells.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Long-term follow-up indicated that the transitory presence of such a small number of cells producing such small amounts of MaIFN-\u03b2 did not prevent animals from the progressive decrease in CD4<jats:sup>+<\/jats:sup> cell count typical of infection with simian immunodeficiency virus. These results reveal potential pitfalls for future developments of gene therapy strategies of HIV infection.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1742-4690-1-29","type":"journal-article","created":{"date-parts":[[2004,9,30]],"date-time":"2004-09-30T06:23:47Z","timestamp":1096525427000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Low autocrine interferon beta production as a gene therapy approach for AIDS: Infusion of interferon beta-engineered lymphocytes in macaques chronically infected with SIVmac251"],"prefix":"10.1186","volume":"1","author":[{"given":"Wilfried","family":"Gay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Lauret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Boson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9rome","family":"Larghero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Matheux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Peyramaure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Dormont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"De Maeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Le Grand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,9,25]]},"reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/106002809603000111","volume":"30","author":"SC Piscitelli","year":"1996","unstructured":"Piscitelli SC, Minor JR, Saville MW, Davey RT: Immune-based therapies for treatment of HIV infection. Ann Pharmacother. 1996, 30: 62-76.","journal-title":"Ann Pharmacother"},{"key":"29_CR2","first-page":"209","volume":"11","author":"JB Angel","year":"2001","unstructured":"Angel JB: Improving immune function and controlling viral replication in HIV-1-infected patients with immune-based therapies. AIDS Read. 2001, 11: 209-221.","journal-title":"AIDS Read"},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/aid.1990.6.1023","volume":"6","author":"RS Kornbluth","year":"1990","unstructured":"Kornbluth RS, Munis JR, Oh PS, Meylan PR, Richman DD: Characterization of a macrophage-tropic HIV strain that does not alter macrophage cytokine production yet protects macrophages from superinfection by vesicular stomatitis virus. AIDS Res Hum Retroviruses. 1990, 6: 1023-1036.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"29_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1126\/science.2470148","volume":"244","author":"G Poli","year":"1989","unstructured":"Poli G, Orenstein JM, Kinter A, Folks TM, Fauci AS: Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science. 1989, 244: 575-577.","journal-title":"Science"},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1128\/jvi.66.12.7543-7548.1992","volume":"66","author":"BD Hansen","year":"1992","unstructured":"Hansen BD, Nara PL, Maheshwari RK, Sidhu GS, Bernbaum JG, Hoekzema D, Meltzer D, Gendelman HE: Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120. J Virol. 1992, 66: 7543-7548.","journal-title":"J Virol"},{"key":"29_CR6","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1128\/jvi.68.11.7559-7565.1994","volume":"68","author":"L Baca-Regen","year":"1994","unstructured":"Baca-Regen L, Heinzinger N, Stevenson M, Gendelman HE: Alpha interferon-induced antiretroviral activities: restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes. J Virol. 1994, 68: 7559-7565.","journal-title":"J Virol"},{"key":"29_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1006\/viro.1993.1126","volume":"193","author":"Y Shirazi","year":"1993","unstructured":"Shirazi Y, Pitha PM: Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology. 1993, 193: 303-312. 10.1006\/viro.1993.1126.","journal-title":"Virology"},{"key":"29_CR8","doi-asserted-by":"crossref","first-page":"23087","DOI":"10.1016\/S0021-9258(17)31623-X","volume":"269","author":"EM Coccia","year":"1994","unstructured":"Coccia EM, Krust B, Hovanessian AG: Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment. J Biol Chem. 1994, 269: 23087-23094.","journal-title":"J Biol Chem"},{"key":"29_CR9","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1073\/pnas.91.7.2689","volume":"91","author":"V Vieillard","year":"1994","unstructured":"Vieillard V, Lauret E, Rousseau V, De Maeyer E: Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta. Proc Natl Acad Sci U S A. 1994, 91: 2689-2693.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29_CR10","doi-asserted-by":"publisher","first-page":"11595","DOI":"10.1073\/pnas.94.21.11595","volume":"94","author":"V Vieillard","year":"1997","unstructured":"Vieillard V, Cremer I, Lauret E, Rozenbaum W, Debre P, Autran B, De Maeyer E: Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens. Proc Natl Acad Sci U S A. 1997, 94: 11595-11600. 10.1073\/pnas.94.21.11595.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1699-0463.1995.tb01092.x","volume":"103","author":"F Belardelli","year":"1995","unstructured":"Belardelli F: Role of interferons and other cytokines in the regulation of the immune response. Apmis. 1995, 103: 161-179.","journal-title":"Apmis"},{"key":"29_CR12","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1089\/10430349950017482","volume":"10","author":"F Hadida","year":"1999","unstructured":"Hadida F, De Maeyer E, Cremer I, Autran B, Baggiolini M, Debre P, Vieillard V: Acquired constitutive expression of interferon beta after gene transduction enhances human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity by a RANTES-dependent mechanism. Hum Gene Ther. 1999, 10: 1803-1810. 10.1089\/10430349950017482.","journal-title":"Hum Gene Ther"},{"key":"29_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00126334-199101000-00006","volume":"4","author":"AE Goldfeld","year":"1991","unstructured":"Goldfeld AE, Birch-Limberger K, Schooley RT, Walker BD: HIV-1 infection does not induce tumor necrosis factor-alpha or interferon-beta gene transcription. J Acquir Immune Defic Syndr. 1991, 4: 41-47.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"29_CR14","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1128\/jvi.65.11.6362-6364.1991","volume":"65","author":"J Szebeni","year":"1991","unstructured":"Szebeni J, Dieffenbach C, Wahl SM, Venkateshan CN, Yeh A, Popovic M, Gartner S, Wahl LM, Peterfy M, Freidman RM, Weinstein JN: Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures. J Virol. 1991, 65: 6362-6364.","journal-title":"J Virol"},{"key":"29_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0042-6822(89)90282-1","volume":"168","author":"K Mace","year":"1989","unstructured":"Mace K, Duc Dodon M, Gazzolo L: Restriction of HIV-1 replication in promonocytic cells: a role for IFN-alpha. Virology. 1989, 168: 399-405. 10.1016\/0042-6822(89)90282-1.","journal-title":"Virology"},{"key":"29_CR16","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1084\/jem.172.5.1433","volume":"172","author":"HE Gendelman","year":"1990","unstructured":"Gendelman HE, Friedman RM, Joe S, Baca LM, Turpin JA, Dveksler G, Meltzer MS, Dieffenbach C: A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J Exp Med. 1990, 172: 1433-1442. 10.1084\/jem.172.5.1433.","journal-title":"J Exp Med"},{"key":"29_CR17","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/infdis\/173.5.1107","volume":"173","author":"DR Skillman","year":"1996","unstructured":"Skillman DR, Malone JL, Decker CF, Wagner KF, Mapou RL, Liao MJ, Testa D, Meltzer MS: Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: evidence for drug safety, tolerance, and antiviral activity. J Infect Dis. 1996, 173: 1107-1114.","journal-title":"J Infect Dis"},{"key":"29_CR18","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S0923-2494(05)80053-7","volume":"145","author":"E Lauret","year":"1994","unstructured":"Lauret E, Vieillard V, Rousseau V, De Maeyer-Guignard J, De Maeyer E: Exploring interferon beta for gene therapy of HIV infection. Res Immunol. 1994, 145: 674-7. discussion 677\u2013678","journal-title":"Res Immunol"},{"key":"29_CR19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1097\/00002030-199511000-00002","volume":"9","author":"V Vieillard","year":"1995","unstructured":"Vieillard V, Lauret E, Maguer V, Jacomet C, Rozenbaum W, Gazzolo L, De Maeyer E: Autocrine interferon-beta synthesis for gene therapy of HIV infection: increased resistance to HIV-1 in lymphocytes from healthy and HIV-infected individuals. Aids. 1995, 9: 1221-1228.","journal-title":"Aids"},{"key":"29_CR20","doi-asserted-by":"crossref","first-page":"10281","DOI":"10.1128\/JVI.73.12.10281-10288.1999","volume":"73","author":"V Vieillard","year":"1999","unstructured":"Vieillard V, Jouveshomme S, Leflour N, Jean-Pierre E, Debre P, De Maeyer E, Autran B: Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection. J Virol. 1999, 73: 10281-10288.","journal-title":"J Virol"},{"key":"29_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1146\/annurev.iy.08.040190.003013","volume":"8","author":"RC Desrosiers","year":"1990","unstructured":"Desrosiers RC: The simian immunodeficiency viruses. Annu Rev Immunol. 1990, 8: 557-578. 10.1146\/annurev.iy.08.040190.003013.","journal-title":"Annu Rev Immunol"},{"key":"29_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1126\/science.3159089","volume":"228","author":"MD Daniel","year":"1985","unstructured":"Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC: Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science. 1985, 228: 1201-1204.","journal-title":"Science"},{"key":"29_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1089\/10430349950018878","volume":"10","author":"F Matheux","year":"1999","unstructured":"Matheux F, Le Grand R, Rousseau V, De Maeyer E, Dormont D, Lauret E: Macaque lymphocytes transduced by a constitutively expressed interferon beta gene display an enhanced resistance to SIVmac251 infection. Hum Gene Ther. 1999, 10: 429-440. 10.1089\/10430349950018878.","journal-title":"Hum Gene Ther"},{"key":"29_CR24","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1099\/0022-1317-81-11-2741","volume":"81","author":"F Matheux","year":"2000","unstructured":"Matheux F, Lauret E, Rousseau V, Larghero J, Boson B, Vaslin B, Cheret A, De Maeyer E, Dormont D, LeGrand R: Simian immunodeficiency virus resistance of macaques infused with interferon beta-engineered lymphocytes. J Gen Virol. 2000, 81: 2741-2750.","journal-title":"J Gen Virol"},{"key":"29_CR25","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1089\/aid.1996.12.1263","volume":"12","author":"A Cheret","year":"1996","unstructured":"Cheret A, Le Grand R, Caufour P, Dereuddre-Bosquet N, Matheux F, Neildez O, Theodoro F, Maestrali N, Benveniste O, Vaslin B, Dormont D: Cytokine mRNA expression in mononuclear cells from different tissues during acute SIVmac251 infection of macaques. AIDS Res Hum Retroviruses. 1996, 12: 1263-1672.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"29_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1286-4579(03)00144-8","volume":"5","author":"BC Vingert","year":"2003","unstructured":"Vingert BC, Le Grand R, Venet A: Heterogeneity of the simian immunodeficiency virus (SIV) specific CD8(+) T-cell response in mucosal tissues during SIV primary infection. Microbes Infect. 2003, 5: 757-767. 10.1016\/S1286-4579(03)00144-8.","journal-title":"Microbes Infect"},{"key":"29_CR27","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/JVI.73.8.6453-6459.1999","volume":"73","author":"S Fais","year":"1999","unstructured":"Fais S, Lapenta C, Santini SM, Spada M, Parlato S, Logozzi M, Rizza P, Belardelli F: Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation\/differentiation of human target cells at the time of primary infection. J Virol. 1999, 73: 6453-6459.","journal-title":"J Virol"},{"key":"29_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm0298-181","volume":"4","author":"RE Donahue","year":"1998","unstructured":"Donahue RE, Bunnell BA, Zink MC, Metzger ME, Westro RP, Kirby MR, Unangst T, Clements JE, Morgan RA: Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes. Nat Med. 1998, 4: 181-186. 10.1038\/nm0298-181.","journal-title":"Nat Med"},{"key":"29_CR29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V96.3.785.015k10_785_793","volume":"96","author":"RT Mitsuyasu","year":"2000","unstructured":"Mitsuyasu RT, Anton PA, Deeks SG, Scadden DT, Connick E, Downs MT, Bakker A, Roberts MR, June CH, Jalali S, Lin AA, Pennathur-Das R, Hege KM: Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects. Blood. 2000, 96: 785-793.","journal-title":"Blood"},{"key":"29_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/4716","volume":"5","author":"SJ Brodie","year":"1999","unstructured":"Brodie SJ, Lewinsohn DA, Patterson BK, Jiyamapa D, Krieger J, Corey L, Greenberg PD, Riddell SR: In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat Med. 1999, 5: 34-41. 10.1038\/4716.","journal-title":"Nat Med"},{"key":"29_CR31","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1006\/mthe.2002.0611","volume":"5","author":"SG Deeks","year":"2002","unstructured":"Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C, Macken C, Richman DD, Christopherson C, June CH, Lazar R, Broad DF, Jalali S, Hege KM: A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy. Mol Ther. 2002, 5: 788-797. 10.1006\/mthe.2002.0611.","journal-title":"Mol Ther"},{"key":"29_CR32","first-page":"467","volume":"96","author":"RE Walker","year":"2000","unstructured":"Walker RE, Bechtel CM, Natarajan V, Baseler M, Hege KM, Metcalf JA, Stevens R, Hazen A, Blaese RM, Chen CC, Leitman SF, Palensky J, Wittes J, Davey RT Jr, Falloon J, Polis MA, Kovacs JA, Broad DF, Levine BL, Roberts MR, Masur H, Lane HC: Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. Blood. 2000, 96: 467-474.","journal-title":"Blood"},{"key":"29_CR33","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1126\/science.272.5270.1939","volume":"272","author":"BL Levine","year":"1996","unstructured":"Levine BL, Mosca JD, Riley JL, Carroll RG, Vahey MT, Jagodzinski LL, Wagner KF, Mayers DL, Burke DS, Weislow OS, St Louis DC, June CH: Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science. 1996, 272: 1939-1943.","journal-title":"Science"},{"key":"29_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1126\/science.276.5310.273","volume":"276","author":"RG Carroll","year":"1997","unstructured":"Carroll RG, Riley JL, Levine BL, Feng Y, Kaushal S, Ritchey DW, Bernstein W, Weislow OS, Brown CR, Berger EA, June CH, St Louis DC: Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells. Science. 1997, 276: 273-276. 10.1126\/science.276.5310.273.","journal-title":"Science"},{"key":"29_CR35","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1128\/JVI.75.22.10843-10855.2001","volume":"75","author":"M Paiardini","year":"2001","unstructured":"Paiardini M, Galati D, Cervasi B, Cannavo G, Galluzzi L, Montroni M, Guetard D, Magnani M, Piedimonte G, Silvestri G: Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals. J Virol. 2001, 75: 10843-55. 10.1128\/JVI.75.22.10843-10855.2001.","journal-title":"J Virol"},{"key":"29_CR36","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.4049\/jimmunol.164.3.1582","volume":"164","author":"I Cremer","year":"2000","unstructured":"Cremer I, Vieillard V, De Maeyer E: Retrovirally mediated IFN-beta transduction of macrophages induces resistance to HIV, correlated with up-regulation of RANTES production and down-regulation of C-C chemokine receptor-5 expression. J Immunol. 2000, 164: 1582-1587.","journal-title":"J Immunol"},{"key":"29_CR37","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1172\/JCI113746","volume":"82","author":"AS Lau","year":"1988","unstructured":"Lau AS, Read SE, Williams BR: Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome. J Clin Invest. 1988, 82: 1415-21.","journal-title":"J Clin Invest"},{"key":"29_CR38","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1126\/science.279.5354.1223","volume":"279","author":"H Mohri","year":"1998","unstructured":"Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD: Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science. 1998, 279: 1223-1227. 10.1126\/science.279.5354.1223.","journal-title":"Science"},{"key":"29_CR39","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1073\/pnas.95.11.6388","volume":"95","author":"M Rosenzweig","year":"1998","unstructured":"Rosenzweig M, DeMaria MA, Harper DM, Friedrich S, Jain RK, Johnson RP: Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc Natl Acad Sci U S A. 1998, 95: 6388-6393. 10.1073\/pnas.95.11.6388.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29_CR40","first-page":"13","volume":"1","author":"M Yu","year":"1994","unstructured":"Yu M, Poeschla E, Wong-Staal F: Progress towards gene therapy for HIV infection. Gene Ther. 1994, 1: 13-26.","journal-title":"Gene Ther"},{"key":"29_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0140-6736(95)90407-7","volume":"345","author":"SH Bridges","year":"1995","unstructured":"Bridges SH, Sarver N: Gene therapy and immune restoration for HIV disease. Lancet. 1995, 345: 427-432. 10.1016\/S0140-6736(95)90407-7.","journal-title":"Lancet"},{"key":"29_CR42","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1089\/10430340050111340","volume":"11","author":"I Cremer","year":"2000","unstructured":"Cremer I, Vieillard V, Sautes-Fridman C, De Maeyer E: Inhibition of human immunodeficiency virus transmission to CD4+ T cells after gene transfer of constitutively expressed interferon beta to dendritic cells. Hum Gene Ther. 2000, 11: 1695-1703. 10.1089\/10430340050111340.","journal-title":"Hum Gene Ther"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-1-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:30:37Z","timestamp":1728304237000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-1-29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-1-29","relation":{},"ISSN":["1742-4690"],"issn-type":[{"type":"electronic","value":"1742-4690"}],"subject":[],"published":{"date-parts":[[2004,9,25]]},"assertion":[{"value":"3 September 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"29"}}